David E. Ehmann
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Cancer therapeutics and mechanisms 10
- Biochemical and Structural Characterization 3
- Muscle Physiology and Disorders 3
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 9
- Microbial Natural Products and Biosynthesis 6
- Co-authors
- Christopher T. Walsh (6 shared papers)Stewart L. Fisher (7 shared papers)Rong-Fang Gu (3 shared papers)Haris Jahić (5 shared papers)Grant K. Walkup (4 shared papers)Philip L. Ross (3 shared papers)Jun Hu (2 shared papers)Sushmita D. Lahiri (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Biochemistry (2 papers)Journal of Medicinal Chemistry (2 papers)ChemBioChem (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesUnited KingdomBrazil
In The Last Decade
David E. Ehmann
30 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 1.1k
- Applied Microbiology and Biotechnology 165
- Pharmacology 952
- Endocrinology 138
- Toxicology 64
Countries citing papers authored by David E. Ehmann
This map shows the geographic impact of David E. Ehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Ehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Ehmann more than expected).
Fields of papers citing papers by David E. Ehmann
This network shows the impact of papers produced by David E. Ehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Ehmann. The network helps show where David E. Ehmann may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Ehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 441 | |
| 2 | 2013 | 317 | |
| 3 | 2015 | 199 | |
| 4 | 1999 | 147 | |
| 5 | 2015 | 119 | |
| 6 | 2000 | 103 | |
| 7 | 2000 | 94 | |
| 8 | 2014 | 89 | |
| 9 | 2011 | 88 | |
| 10 | 2016 | 74 | |
| 11 | 2015 | 69 | |
| 12 | 2014 | 69 | |
| 13 | 2012 | 69 | |
| 14 | 2001 | 67 | |
| 15 | 1998 | 57 | |
| 16 | 1997 | 50 | |
| 17 | 2015 | 44 | |
| 18 | 2000 | 41 | |
| 19 | 2014 | 40 | |
| 20 | 2003 | 37 |
About David E. Ehmann
David E. Ehmann is a scholar working on Molecular Biology, Pharmacology, Molecular Medicine, Materials Chemistry and Infectious Diseases, having authored 30 papers that have together received 2.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Cancer therapeutics and mechanisms (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Microbial Natural Products and Biosynthesis (6 papers), Biochemical and Structural Characterization (3 papers), Muscle Physiology and Disorders (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Applied Microbiology and Biotechnology (165 citations), Pharmacology (952 citations), Endocrinology (138 citations) and Toxicology (64 citations). David E. Ehmann has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Christopher T. Walsh, Stewart L. Fisher, Rong-Fang Gu, Haris Jahić, Grant K. Walkup, Philip L. Ross, Jun Hu, Sushmita D. Lahiri, Günther Kern and Jason Thresher. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Biochemistry, Journal of Medicinal Chemistry, ChemBioChem and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.